Late Discovery
Overview
WiseGen provides a full range of cell line development solutions from gene to GMP working cell bank, helping our customers accelerate the process of biologics from early R&D to commercial production.Relying on advanced vector construction, high-throughput screening platform and rich industry experience, we are committed to delivering high-yield, high-stability and regulatory-compliant cell lines to our customers.
CHO K1 cell line-based stable cell line
development platform for high expression
We have over 5 years of experience in developing mammalian expressed antibodies with proprietary hosts, vectors, and media, which meet the needs of cell line development for a wide range of molecule types. Multiple combinations of screening strategies to meet the needs of different speeds of IND filing, supporting the fastest IND submission of 9 months. WiseHealth has successfully expressed more than 100+ projects, and 20+ projects are in clinical trials, thanks to the robust screening system.
Contact Info
Fill in the information in the form, and we will provide you with more accurate recommendation information.
I understand and agree to use and transfer my personal information in accordance with the privacy statement